CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 29, 2004--Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Merrill Lynch on Wednesday, February 4, 2004 at 3:35pm EST. The presentation will be webcast from the The Grand Hyatt Hotel in New York and may be accessed under the investor relation's tab at www.alkermes.com. The presentation will be archived for 14 days.
Alkermes, Inc. is an emerging pharmaceutical company developing products based on its sophisticated drug delivery technologies to enhance therapeutic outcomes. Our areas of focus include: controlled, extended-release of injectable drugs utilizing our ProLease(R) and Medisorb(R) delivery systems and the development of inhaled pharmaceutical products based on our proprietary Advanced Inhalation Research, Inc., ("AIR(R)") pulmonary delivery system. Our business strategy is twofold. We partner our proprietary technology systems and drug delivery expertise with many of the world's finest pharmaceutical companies and also develop novel, proprietary drug candidates for our own account. In addition to our Massachusetts headquarters, research and manufacturing facilities, we operate research and manufacturing facilities in Ohio.
CONTACT: Alkermes, Inc.
Rebecca Peterson, 617-583-6378
SOURCE: Alkermes, Inc.